Semi-Annual Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7320763

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income
Statement of income
Ordinary profit (loss)
-1,426,891,000 JPY
-1,325,760,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
77,149,000 JPY
87,200,000 JPY
Taxes and dues
56,262,000 JPY
43,374,000 JPY
Profit (loss) before income taxes
-1,426,891,000 JPY
-1,325,760,000 JPY
Operating profit (loss)
-1,403,464,000 JPY
-1,315,810,000 JPY
Income taxes - current
2,502,000 JPY
3,028,000 JPY
Non-operating income
16,000 JPY
45,000 JPY
Non-operating income
Interest income
14,000 JPY
13,000 JPY
Non-operating expenses
23,443,000 JPY
9,995,000 JPY
Income taxes
2,502,000 JPY
3,028,000 JPY
Profit (loss)
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,328,788,000 JPY
-1,328,788,000 JPY
-1,328,788,000 JPY
-1,328,788,000 JPY
Non-operating expenses

Talk to a Data Expert

Have a question? We'll get back to you promptly.